189 related articles for article (PubMed ID: 35928267)
1. The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA).
Xie R; Xie M; Zhu L; Chiu JWY; Lam W; Yap DYH
Front Pharmacol; 2022; 13():930951. PubMed ID: 35928267
[No Abstract] [Full Text] [Related]
2. Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma.
You J; Li H; Wei Y; Fan P; Zhao Y; Yi C; Guo Q; Yang X
Front Oncol; 2022; 12():881860. PubMed ID: 35847844
[TBL] [Abstract][Full Text] [Related]
3. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.
Wu T; Li S; Yu C; Wu Y; Long H
Sci Rep; 2022 Dec; 12(1):21467. PubMed ID: 36509838
[TBL] [Abstract][Full Text] [Related]
4. Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma.
Deng D; Liu F; Liu Z; Wu Z; He Y; Zhang C; Zu X; Ou Z; Wang Y
Front Immunol; 2022; 13():965469. PubMed ID: 36090967
[TBL] [Abstract][Full Text] [Related]
5. Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer.
Zhao J; Wu C; Wang Y; Li M; Jiang Y; Luo Y
Transl Cancer Res; 2022 Jul; 11(7):1865-1879. PubMed ID: 35966309
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.
Mi Y; Wang X
J Environ Pathol Toxicol Oncol; 2022; 41(3):1-12. PubMed ID: 35993952
[TBL] [Abstract][Full Text] [Related]
7. A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma.
Wang C; Chen S; Li S; Mi H
Front Genet; 2022; 13():708003. PubMed ID: 35251120
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration.
Huang C; Li Y; Ling Q; Wei C; Fang B; Mao X; Yang R; Zhang L; Huang S; Cheng J; Liao N; Wang F; Mo L; Mo Z; Li L
FEBS Open Bio; 2023 Apr; 13(4):736-750. PubMed ID: 36814419
[TBL] [Abstract][Full Text] [Related]
9. CXCL12, a potential modulator of tumor immune microenvironment (TIME) of bladder cancer: From a comprehensive analysis of TCGA database.
Wang J; Xie Y; Qin D; Zhong S; Hu X
Front Oncol; 2022; 12():1031706. PubMed ID: 36419891
[TBL] [Abstract][Full Text] [Related]
10. Analysis of prognostic oncogene filaggrin (
Chen L; Huang X; Xiong L; Chen W; An L; Wang H; Hong Y; Wang H
Transl Androl Urol; 2022 Oct; 11(10):1419-1432. PubMed ID: 36386263
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
[TBL] [Abstract][Full Text] [Related]
12. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
Lv Y; Jin P; Chen Z; Zhang P
Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma.
Wang Y; Zhu H; Wang X
Front Genet; 2022; 13():965100. PubMed ID: 36186448
[No Abstract] [Full Text] [Related]
15. The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis.
Zhang Y; Wang Y; Wang J; Zhang K
Front Genet; 2022; 13():852708. PubMed ID: 35801082
[No Abstract] [Full Text] [Related]
16. High expression of
Lin B; Zhang T; Ye X; Yang H
Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
[TBL] [Abstract][Full Text] [Related]
17. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
18. CASP4 and CASP8 as newly defined autophagy-pyroptosis-related genes associated with clinical and prognostic features of renal cell carcinoma.
Li T; Liu N; Zhang G; Chen M
J Cancer Res Ther; 2022 Dec; 18(7):1952-1960. PubMed ID: 36647955
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Kang Y; Zhu X; Wang X; Liao S; Jin M; Zhang L; Wu X; Zhao T; Zhang J; Lv J; Zhu D
Front Oncol; 2021; 11():641184. PubMed ID: 33816287
[TBL] [Abstract][Full Text] [Related]
20. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
Front Oncol; 2022; 12():904464. PubMed ID: 35912258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
